JANX
Janux Therapeutics
$18.05
+$0.79 (+4.58%)Oct 28, 2026
Key metrics
The numbers that frame JANX today
- Market cap
- $1.10B
- Gross margin
- 100%
- EV / Sales
- 45.7
- ROIC
- -10.8%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $12.12
- 52wk High
- $35.34
Growth
Revenue and earnings trend for JANX
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about JANX
Is Janux Therapeutics a good buy?
Hold. Janux Therapeutics has strong momentum, but weak quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Janux Therapeutics is selling at a high price.
What is the market capitalization of JANX?
Janux Therapeutics's market capitalization is $1.10B.
What is the 52-week high for JANX stock?
The 52-week high for Janux Therapeutics is $35.34. The current close of $18.05 is 48.9% below that high.
What is the 52-week low for JANX stock?
The 52-week low for Janux Therapeutics is $12.12. The current close of $18.05 is 48.9% above that low.
Does JANX stock pay dividends?
Janux Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for JANX?
Janux Therapeutics's Debt / Equity ratio is 0.02.